Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona By Watertime - April 24, 2026 15 Post Content RELATED ARTICLESMORE FROM AUTHOR Pα+ Psychedelic Bulletin #228: Inside the Lilly-Atai Deal; An Update on the GH-AtaiBeckley Patent Standoff; Field Reacts to FDA’s Guidance; Resilient Readies Resubmission Q3’26 Psychedelic Drug Development Pipeline: Bullseye Charts The Vital Conference: Breckenridge 2026
